Edurant and Crixivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Edurant (rilpivirine hydrochloride) and Crixivan (indinavir sulfate). Common drug interactions include quality of life decreased among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Edurant and Crixivan. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Edurant?

Edurant has active ingredients of rilpivirine hydrochloride. eHealthMe is studying from 2,238 Edurant users. Check the latest studies of Edurant.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.



On Jul, 12, 2026

47 people who take Edurant and Crixivan together, and have interactions are studied.

Edurant and Crixivan drug interactions.

What are the common drug interactions of Edurant and Crixivan, by gender? *:

female:

  1. Quality of life decreased
  2. Spinal compression fracture (fracture due to spinal compression on bone)
  3. Visual acuity reduced (reduced clearness of vision)
  4. Emotional distress
  5. Pain
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Osteoporosis (bones weak and more likely to break)
  9. Renal failure (kidney dysfunction)
  10. Hip fracture

male:

  1. Emotional distress
  2. Pain
  3. Mobility decreased (ability to move is reduced)
  4. Renal failure (kidney dysfunction)
  5. Renal impairment (severely reduced kidney function)
  6. Bone loss
  7. Decreased activity
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Multiple fractures

What are the common drug interactions of Edurant and Crixivan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Emotional distress
  3. Hypertensive nephropathy (hypertensive renal disease)
  4. Osteomalacia (softening of the bones due to a lack of vitamin d)
  5. Pain
  6. Renal failure (kidney dysfunction)

40-49:

  1. Quality of life decreased
  2. Renal impairment (severely reduced kidney function)
  3. Spinal compression fracture (fracture due to spinal compression on bone)
  4. Upper limb fracture
  5. Anxiety
  6. Emotional distress
  7. Pain
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Depression
  10. Osteopenia (a condition where bone mineral density is lower than normal)

50-59:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Chronic kidney disease
  6. Depression
  7. Hip fracture
  8. Multiple fractures
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Decreased activity
  5. Depression
  6. Mobility decreased (ability to move is reduced)
  7. Quality of life decreased
  8. Renal cyst (kidney cyst)
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

  1. Hiv Infection: 45 people, 95.74%
  2. High Blood Pressure: 8 people, 17.02%
  3. High Blood Cholesterol: 7 people, 14.89%
  4. Depression: 7 people, 14.89%
  5. Stress And Anxiety: 6 people, 12.77%
  6. Pain: 6 people, 12.77%
  7. Laxative Supportive Care: 6 people, 12.77%
  8. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 6 people, 12.77%
  9. Hypersensitivity: 5 people, 10.64%
  10. Bacterial Infection: 5 people, 10.64%

* Approximation only. Some reports may have incomplete information.

Do you take Edurant and Crixivan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Edurant and Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Edurant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crixivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rilpivirine hydrochloride and indinavir sulfate (the active ingredients of Edurant and Crixivan, respectively), and Edurant and Crixivan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: